Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review B. CabarrouL. MoureyThomas Filleron Review 09 May 2017 Pages: 505 - 513
Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer Kathryn J. RuddyHolly K. Van HoutenNilay Shah Review 10 May 2017 Pages: 515 - 525
Critical appraisal of health-state utility values used in breast cancer-related cost–utility analyses Virginie NerichSopany SaingGeorg Kemmler Review 11 May 2017 Pages: 527 - 536
Risk of death from cardiovascular disease following breast cancer: a systematic review S. A. M. GernaatP. J. HoH. M. Verkooijen Review Open access 13 May 2017 Pages: 537 - 555
Benefit of adding digital breast tomosynthesis to digital mammography for breast cancer screening focused on cancer characteristics: a meta-analysis Seong Jong YunChang-Woo RyuJi Young Oh Review 18 May 2017 Pages: 557 - 569
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab) Diep HoJessica HuangAllan Lipton Preclinical study 08 May 2017 Pages: 571 - 580
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis Gail D. Lewis PhillipsMerry C. NishimuraHeidi S. Phillips Preclinical study Open access 10 May 2017 Pages: 581 - 591
Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer Seth K. RummelLeann LovejoyRachel E. Ellsworth Preclinical study 13 May 2017 Pages: 593 - 601
Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer Madhura G. KelkarBhushan ThakurAbhijit De Preclinical study 20 May 2017 Pages: 603 - 615
A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy Ji-Yeon KimOh Nam OkYeon Hee Park Clinical trial 09 May 2017 Pages: 617 - 625
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer Kara N. MaxwellDanielle Soucier-ErnstAngela DeMichele Clinical trial 12 May 2017 Pages: 627 - 638
Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer Kara N. MaxwellDanielle Soucier-ErnstAngela DeMichele Erratum 26 June 2017 Pages: 639 - 640
Radiation and depression associated with complications of tissue expander reconstruction Paul J. ChubaWilliam A. StefaniAmr Aref Clinical trial 13 May 2017 Pages: 641 - 647
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer Denise A. YardleyEdward R. ArrowsmithHoward A. Burris III Clinical Trial 15 May 2017 Pages: 649 - 658
Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography Elizabeth A. RaffertyStephen L. RoseLoren T. Niklason Clinical trial 18 May 2017 Pages: 659 - 666
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers Cecilia AhlinClaudia LundgrenM. -L. Fjällskog Clinical trial Open access 20 May 2017 Pages: 667 - 678
Aesthetic result after breast-conserving therapy is associated with quality of life several years after treatment. Swedish women evaluated with BCCT.core and BREAST-Q™ Cecilia DahlbäckJenny Heiman UllmarkJonas Manjer Clinical trial Open access 23 May 2017 Pages: 679 - 687
Elevated T cell activation score is associated with improved survival of breast cancer Lingeng LuYalai BaiZuoheng Wang Epidemiology 09 May 2017 Pages: 689 - 696
Childhood and teenage physical activity and breast cancer risk Nicole M. NiehoffAlexandra J. WhiteDale P. Sandler Epidemiology 12 May 2017 Pages: 697 - 705
Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction Molly Scannell BryanMaria ArgosHabibul Ahsan Epidemiology 13 May 2017 Pages: 707 - 717
Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results Anand NarayanAlexander FischerSusan Harvey Epidemiology 15 May 2017 Pages: 719 - 725
Women with breast cancer report substantially more disease- and treatment-related side or late effects than registered by clinical oncologists: a cross-sectional study of a standard follow-up program in an oncological department Mai-Britt Bjørklund EllegaardCai GrauAnders Bonde Jensen Epidemiology 23 May 2017 Pages: 727 - 736
Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients Andy GöbelJan D. KuhlmannTilman D. Rachner Brief Report 19 May 2017 Pages: 737 - 743
Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications Jessica A. Cintolo-GonzalezDanielle BraunKevin S. Hughes Erratum 21 June 2017 Pages: 745 - 745
